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Abstract Flotillin-1 is a lipid raft-associated protein involved
in neuronal regeneration, insulin signaling in adipocytes, and
phagosome maturation in macrophages. We detected abundant
£otillin-1 mRNA expression in con£uent cultures of mouse
NIH-3T3 ¢broblasts. These cells were used as a model to assess
the regulation of £otillin-1 mRNA and protein expression by
cell^cell interactions. The disruption of cell^cell interactions
triggered the downregulation of the £otillin-1 gene. However,
the establishment of new cell interactions, and ¢nally con£u-
ence, increased both the £otillin-1 transcript and its protein.
Despite £otillin-1 having been described as an integral protein
of the cell membrane, it is also very conspicuous in the hydro-
philic fraction (the non-membrane fraction) of con£uent cell
extracts. The promoter region of the £otillin-1 gene was isolated
and analyzed by transfection experiments, and the regulatory
domains containing motifs for binding transcription factors in-
volved in cell di¡erentiation were identi¢ed.
, 2003 Federation of European Biochemical Societies. Pub-
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1. Introduction
Lipid rafts are dynamic subdomains of the plasma mem-
brane enriched in speci¢c, highly ordered glycosphingolipids
and cholesterol ^ molecules that confer the biophysical prop-
erties that allow their puri¢cation [1]. Lipid rafts can recruit a
multitude of proteins including glycosylphosphatidylinositol-
anchored proteins and acylated proteins such as the Src family
kinases and the caveolins. Caveolins are components of spe-
cial, £ask-shaped lipid rafts ^ the caveolae [2].
Lipid rafts are involved in important cell processes such as
the polarized sorting of apical membrane proteins in epithelial
cells and signal transduction [3]. They also participate in the
assembly of cell adhesion complexes in which the actin cyto-
skeleton is involved [4]. Cell adhesion complexes are critical
for the physical coordination of cell interactions.
The proteins of the £otillin/reggie family are important
components of lipid rafts. Although both £otillins and caveo-
lins were recently described as novel constituents of raft do-
mains and caveolae [5,6], £otillins are present in cells that lack
morphologically de¢nable caveolae and have been localized in
non-caveolar membranes [7,8]. Reggie-1 and reggie-2 were
originally identi¢ed in the regenerating neurons of gold¢sh
optic nerves [9] and later in endothelial cells, where they
were termed £otillin-2 and £otillin-1 (£o-1) respectively [5]
[6]. In addition to their postulated role in neuronal regener-
ation, £otillin-1/reggie-2 has been implicated in insulin signal-
ing that triggers glucose transporter redistribution in adipo-
cytes [10]. Flotillin-1 also associates with phagosomes in
macrophages [11]. Flotillin-1 and £otillin-2 are highly con-
served genes with orthologs in mouse, rat, human, ¢sh and
Drosophila [7,9,12^14]. We have observed £otillin-1 overex-
pression in Sertoli cell cultures when cell interactions are
chemically altered (manuscript in preparation).
The present paper analyzes the regulation of £o-1 by cell^
cell interactions in a cultured NIH-3T3 ¢broblast experimen-
tal model. The pattern of mRNA and protein accumulation
was followed after disruption of cell^cell interactions through
to the re-establishment of intercellular contacts. The di¡eren-
tial localization of £o-1 in the membrane and hydrophilic
fractions of cell extracts ^ depending on cell interactions ^
suggests new roles for £o-1 in the cell.
The mouse promoter region of £o-1 was also isolated and
characterized in order to study the regulatory motifs possibly
involved in the modulation of £o-1 expression.
2. Materials and methods
2.1. Gene isolation and characterization
A cDNA clone corresponding to the £o-1 gene was isolated in gene
regulation experiments involving Sertoli cell cultures (data not
shown).
From a mouse genomic library constructed in lambda phages, two
overlapping phages were isolated and restriction-digested for mapping
(Fig. 1). Sequence analysis of both phages and database comparisons
showed a sequence corresponding to the ¢rst eight exons of £o-1, an
upstream region corresponding to the £o-1 promoter region, and the
gly96 gene.
Sequencing was carried out with an ABI Prism 3700 DNA analyzer
(Applied Biosystems). Sequence comparisons were performed by nu-
cleotide BLAST at the NCBI (http://www.ncbi.nlm.nih.gov/BLAST/).
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2.2. Reporter gene constructs
Fusion gene constructs were made between £o-1 promoter frag-
ments and the luciferase reporter gene (Fig. 3). The promoter frag-
ments fP1 (556 bp from nucleotide 4079 to 4634 in AY168443), fP2
(412 bp from nucleotide 4223 to 4634 in AY168443) and fP4 (173 bp
from nucleotide 4462 to 4634 in AY168443) were obtained by poly-
merase chain reaction (PCR) using phage V31a1 from the genomic
library (see Section 3) as a template. Speci¢c primers were designed
from the putative promoter region. The reverse primer was the same
in all primer combinations; it carried a BglII target sequence at the 5P
end (small letters in fP-R sequence). The oligonucleotide sequences
were: fP1-F, 5P-CTGTGAACACGAATAAACTT-3P (forward); fP2-
F, 5P-CTTGGAGTTACAGACCTATA-3P (forward); fP4-F, 5P-GG-
CTGCCGAGAACTGTA-3P (forward); fP-R, 5P-gaagatcttcAACGG-
GGTGGGGACTGC-3P (reverse).
The PCR pro¢le was: 10 min at 95‡C, 35 cycles of 15 s at 95‡C, 30 s
at 60‡C and 1 min at 72‡C, and an additional elongation step for 10
min at 72‡C. All PCR products were cloned in pGEM-T Easy vector
(Promega), according to the manufacturer’s instructions. Inserts from
each plasmid construct were released by EcoRI and BglII digestion.
Puri¢ed inserts were then cloned in luciferase expression vector pGL3-
basic (Promega). All resultant constructs were veri¢ed by sequencing.
2.3. Culture and transient transfection of NIH-3T3 cells
Mouse embryonic ¢broblasts NIH-3T3 were cultured in a 5% CO2/
95% air atmosphere at 37‡C in Dulbecco’s modi¢ed Eagle’s medium
(Gibco BRL) supplemented with 10% heat-inactivated fetal bovine
serum, 2 mM L-glutamine, 100 U/ml penicillin, and 100 Wg/ml strep-
tomycin.
Con£uent NIH-3T3 cells cultured in 100U20 mm Style Standard
dishes (BD Falcon) were detached by trypsin treatment. Dissociated
cells were then distributed into new dishes (8U105 cells/dish) and
allowed to grow for 96 h to regain con£uence. Total RNA samples
were obtained from trypsinized cells at 24 h, 48 h, 72 h and 96 h.
Subcon£uent NIH-3T3 cells growing in 12-well cell culture plates
(BD Falcon) were transiently cotransfected with 1 Wg of recombinant
pGL3-basic constructs plus 0.2 Wg of RSV-L-Gal plasmid as an inter-
nal control for transfection e⁄ciency. As a vehicle for transfection,
the FuGENE 6 transfection reagent (Roche Applied Science) was
used following the manufacturer’s instructions. After 24 h, cell lysates
were prepared from the transfected cells using Passive Lysis Bu¡er
(Promega). As a negative control of promoter activity we also trans-
fected empty pGL3-basic. Each experiment was replicated at least
three times. Luciferase activity was measured in cell lysates with the
Luciferase Assay System (Promega) using a luminometer (TD-20/20,
Promega) according to the manufacturer’s instructions. L-Galactosi-
dase activity was assayed according to standard procedures [15] with
o-nitrophenyl-L-D-galactopyranoside; A420 was measured in an auto-
mated ELISA reader (Labsystems Multiskan Bichromatic, Helsinki,
Finland).
2.4. Northern blots
Total RNA from NIH-3T3 cell cultures at di¡erent stages of
growth (see Section 3) were extracted by RNAwiz (RNA isolation
reagent [Ambion]) following the manufacturer’s instructions. The
mRNA samples (15 Wg) were electrophoretically separated under de-
naturing conditions (1% agarose/8% formaldehyde) and transferred to
nylon. Prehybridization and hybridization with [K-32P]dCTP-labeled
£otillin-1 and S16 ribosomal protein cDNAs were performed in
Church solution [16] for 1 h at 65‡C and overnight at 68‡C respec-
tively. Membranes were washed and X-ray ¢lm exposed for 3 days at
380‡C. [K-32P]dCTP-labeled S16 ribosomal protein cDNA was used as
a probe for the loading control [17].
2.5. Western blots
To analyze the £otillin-1 protein in NIH-3T3 cells we prepared
protein extracts from the hydrophobic (membrane) and hydrophilic
fractions using the Mem-PER Eukaryotic Membrane Protein Extrac-
tion Reagent kit (Pierce). This kit is based on the separation of plas-
ma membrane proteins by the technique of aqueous two-phase parti-
tion [18^20]. Protein fractions obtained from 7U104 cells from
trypsinized cultures at di¡erent growth stages (see Section 3) were
separated by sodium dodecyl sulfate^polyacrylamide gel electrophore-
sis (SDS^PAGE) on 12% polyacrylamide gels [21] and electrophoreti-
cally transferred to polyvinylidene di£uoride membranes according to
Towbin [22]. A replica of protein separation (10% polyacrylamide gel)
was visualized by Coomassie blue staining in order to check the load-
ing (Fig. 5A). Filters were probed with mouse monoclonal antibody
against £otillin-1 (BD Transduction Laboratories). As a control of the
hydrophobic/hydrophilic protein separation, the ¢lters were stripped
and reprobed with rabbit polyclonal antibody against caveolin (BD
Transduction Laboratories) as an integral membrane protein. We
used peroxidase-conjugated anti-mouse IgG or anti-rabbit IgG
(Amersham Biosciences) as secondary antibodies. The blots were de-
veloped using the ECL Western blotting analysis system (Amersham
Biosciences) and exposed to X-ray ¢lm.
3. Results
3.1. Characterization of the mouse £otillin-1 gene and
promoter region
From a cDNA clone corresponding to a di¡erentially ex-
pressed gene in Sertoli cells (unpublished results), we screened
a mouse testis cDNA library to isolate the full-length cDNA
corresponding to the £otillin-1 gene (GenBank accession num-
ber AY167925). The 1701 bp cDNA was used to screen a
mouse genomic library using a PstI restriction fragment
(Fig. 1A). Two overlapping phages, V31a1 and V21a1, were
isolated and restriction-digested for mapping analysis (Fig.
1B).
A large fragment (8.2 kb) from V31a1 was sequenced (Fig.
1B) and submitted to GenBank (accession number
AY168443). The genomic sequence was analyzed by compar-
ison with the £o-1 cDNA sequence and eight exons corre-
sponding to the 5P region of the gene were identi¢ed. Com-
parison with databases showed the presence of the gene gly96
in the same strand upstream of £o-1. gly96 is an immediate-
early gene inducible by serum growth factors in mouse ¢bro-
blasts [23]. The chromosomal organization of both genes is
conserved in the human genome where a Ier3 (immediate-early
response 3) ortholog £anks Flotillin-1 in the 5P position [24].
BLAST homology searches for expressed sequence tag
(EST) sequences of this region revealed four ESTs corre-
sponding to the 5P region of £o-1 that do not carry exon 4
in normal nervous tissue (olfactory epithelium, accession
number BU148641, and neonate cortex, accession number
BB873447). The same exon 4 deletion was observed for
ESTs corresponding to mammary tumor (accession numbers
BI156168 and BI157452).
To identify the promoter region of the mouse £o-1 gene, the
456 bp nucleotide sequence of the 5P £anking region (nucleo-
tides 4096^4551 in AY168443) was analyzed to search for
possible transcription factor binding sites with a threshold
score of 90 (Y. Akiyama: ‘TFSEARCH: Searching Transcrip-
tion Factor Binding Sites’, http://www.rwcp.or.jp/papia/ [25]).
After computer analysis with mouse 5P EST databases, our
cDNA was found to be the longest at the 5P end; the ¢rst
nucleotide for transcription was taken to be that at position
4552 (AY168443). This 456 bp region lacks a consensus
TATA box, as occurs in the human ortholog, but several
putative transcription factor binding sites were found (Fig. 2).
There is a putative CpG island (69.18% CG content) span-
ning from nucleotide 4461 to 4739 in AY168443, 72% identi-
cal to the human Flotillin-1 CpG island [24]. The mouse CpG
island (279 bp) is shorter than the human version (545 bp) but
its location in the gene structure (covering exon 1) is the same
(Fig. 3).
To characterize the promoter, we prepared a series of
recombinant plasmids containing di¡erent portions of the
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5P £anking £o-1 sequence inserted upstream of the luciferase
coding region. These were used in transient cotransfection
experiments with NIH-3T3 cells using a L-galactosidase-en-
coding plasmid as the transfection control. Fig. 3 shows
how all constructs were able to trigger the transcription of
luciferase. The shorter segment (fP-4) covering the 5P end of
the CpG island and including the putative Sp1 transcription
factor (Sp1) and zinc ¢nger protein, subfamily 1a, 1 (Ikaros)
(Lyf-1) binding sites led to only basal transcription. The fP-2
segment, with a second Sp1 binding site, a CAAT box and
putative speci¢c binding sites for myeloid zinc ¢nger protein 1
(MZF1), acute myeloid leukemia 1a (AML-1a) and cellular
progenitor of viral oncogene from E26 acute leukemia retro-
virus (c-Ets-1) produced about twice as much luciferase activ-
ity as fP-4. The larger segment, fP-1, which additionally con-
tained a putative MZF1 binding site, promoted about twice as
much luciferase activity as the fP-2 construct and almost six
times as much as fP-4. No activity was detected in the lysate
of cells transfected with the empty pGL3-basic plasmid.
3.2. The expression of £otillin-1 mRNA and protein is related
to cell^cell interaction
Abundant £o-1 RNA expression was detected in NIH-3T3
¢broblasts compared to that reported for other cells and tis-
sues [5]. We therefore took this cell type as a model system to
evaluate the regulation of £o-1 expression mediated by cell^
cell interactions.
We analyzed the level of gene expression by mRNA accu-
mulation in cells cultured at con£uence when all cell interac-
tions are fully established. These interactions were disrupted
by trypsinization and new cultures were established. After 24 h
of subculture, about 50% of the dish surface was occupied by
growing cells. At this stage, the level of £o-1 expression was
reduced to one third of its value at con£uence (Fig. 4, lane 2).
At 48 h of culture, about 75% plate occupancy was observed
and the level of £o-1 was double that at 24 h (Fig. 4, lane 3).
The maximum was reached at 72 h and 96 h when 100%
con£uence was achieved in the culture dishes (Fig. 4, lanes 4
and 5). The level of mRNA at 96 h was the same as the level
of expression detected in trypsinized con£uent cells (Fig. 4,
lane 1).
Fig. 1. Isolation of the £otillin-1 promoter region. A: Diagram showing the location of the PstI restriction fragment in the full-length £otillin-1
cDNA used as a probe in genomic screening. B: Restriction maps of the overlapping clones obtained from the mouse genomic library: V31a1
and V21a1. The PstI probe hybridized with the restriction fragments marked in gray in both phage maps. Below is shown the 8.2 kb sequenced
region with the location of the gly96 gene and the ¢rst eight exons of the £otillin-1 gene. S, Sau3AI; R, EcoRI; X, XbaI; N, NotI.
Fig. 2. Nucleotide sequence of the £otillin-1 promoter. The pro-
moter region is written in lower case letters and extends from the
gly96 polyadenylation signal (marked in italics and bold) to the £o-
tillin-1 transcription start site (marked by s). Putative binding sites
for transcription factors are underlined and indicated. The putative
CpG island is shown in italics. The boundary between exon 1 and
intron 1 is marked with a solid triangle.
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To check whether the £o-1 mRNA regulation detected in
NIH-3T3 cells correlated with an increase in protein expres-
sion, Western blot experiments were performed to detect £o-
tillin-1 in both the hydrophilic and hydrophobic protein ex-
tracts from the stages described above. Protein fractions were
obtained from a de¢ned number of cells (7U104) in each
experimental stage. Total protein balance between samples
was visualized by Coomassie blue staining (Fig. 5A). In
both the hydrophobic and the hydrophilic fractions, a pro-
gressive increase of £o-1 protein was detected associated with
Fig. 3. Functional analysis of the £otillin-1 promoter region. Diagram representing the £otillin-1 promoter region with the location of putative
binding sites for transcription factors. The promoter activities of the constructs with the luciferase reporter transiently transfected into NIH-
3T3 cells are also shown. Left: The locations and sizes of the tested promoter fragments. Right: Luciferase activity as X-fold value compared
to cells transfected with the promoterless pGL3-basic vector normalized with L-galactosidase activity (transfection e⁄ciency control). Data are
the mean and S.D. of triplicates.
Fig. 4. Expression of the £otillin-1 gene in NIH-3T3 cells at di¡er-
ent levels of cell^cell interaction. Northern blot analysis was per-
formed. Total RNA (15 Wg) from cells growing at di¡erent levels of
plate occupancy: (lane 1) RNA from cells at con£uence, immedi-
ately processed after trypsinization; (lane 2) after 24 h of subculture
the cells occupied about 50% of the plate surface; (lane 3) after 48 h
of culture the cells occupied about 75% of the plate surface; lanes 4
and 5: cells were at con£uence after 72 h and 96 h of culture re-
spectively. Hybridization with ribosomal protein S16 probe (rpS16)
was performed as a loading control. A graphic representation is
provided to indicate the dynamics of £otillin-1 expression, from the
disruption of NIH-3T3 cell interactions to their re-establishment.
The y-axis shows the ratio between £otillin-1 values from densito-
metric analyses and the corresponding value of rpS16.
Fig. 5. A: Coomassie blue staining of SDS^PAGE of hydrophilic
(HL) and hydrophobic (HB) fractions obtained from the same num-
ber of NIH-3T3 cells (see Section 2) growing in the same experi-
mental conditions used for Northern blots (lanes 1 and 5, 24 h;
lanes 2 and 6, 48 h; lanes 3 and 7, 72 h; lanes 4 and 8, 96 h).
B: Western blot that shows the accumulation of £otillin-1 (£o-1) in
the hydrophilic and membrane fractions at sequential stages of
NIH-3T3 cell^cell interactions. C: Detection of the integral mem-
brane protein caveolin (cav) as a control of e⁄ciency in the hydro-
phobic/hydrophilic separation. It is interesting to note that caveolin
increases in the membrane fraction in correlation with £otillin-1.
Molecular weight markers are indicated.
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the increase of cell^cell interactions (Fig. 5B). Intriguingly, in
the early stages (24 and 48 h, i.e. before cell con£uence) there
was less protein in the hydrophilic than in the hydrophobic
fraction, but this was reversed at 96 h (at con£uence) (Fig.
5B). Additionally, as is shown in Fig. 5C, the integral mem-
brane protein caveolin was only present at the hydrophobic
fraction; this fact proves the e⁄ciency of the protein extrac-
tion method. Therefore, these experiments demonstrate that
there is a remarkable accumulation of £o-1 outside the mem-
brane in addition to its membrane localization. Moreover, we
detected a progressive increase of caveolin towards cells at
con£uence (Fig. 5C).
These data demonstrate that the level of accumulation of
£otillin-1 transcripts and protein is correlated.
4. Discussion
Our observation of £o-1 deregulation in Sertoli cell culture
might be associated with disorganization of cell^cell interac-
tions (manuscript in preparation). Here, we show that estab-
lishing cell interactions in an NIH-3T3 culture model mediates
the regulation of £o-1 expression. The correlation between
cell^cell interactions and £o-1 expression level was hypothe-
sized following experiments on axon regeneration in the reti-
nal ganglion cells of gold¢sh [9]. In these experiments, Schulte
et al. showed that the £o-1 gold¢sh ortholog, reggie-2, is up-
regulated in retinal ganglion cells during normal axon growth
and regeneration following optic nerve injury. The growing
axons must establish new interactions with the environment
on the way to their target cells. The same has been shown in
rat retinal ganglion cells [7]. In addition, reggie-2 has been
localized, at both light and electron microscopic levels, at
cellular contact sites in cultured, di¡erentiated rat adrenal
pheochromocytoma PC12 neural cells (7 days in the presence
of nerve growth factor) [8].
In our experiments, the modi¢cations carried out in the
culture system were based on the disruption and restoration
of cell contacts. When cell^cell interactions were disrupted,
the level of £o-1 mRNA and protein decreased signi¢cantly.
Therefore, the increase in the level of both mRNA and pro-
tein was concomitant with the restoration of these interac-
tions. This suggests a direct participation of £o-1 in the estab-
lishment of cell^cell interactions ^ or that it is a consequence
of it. According to the participation of £o-1 in the establish-
ment of cell adhesion structures, c-Cbl-associated protein/pon-
sin and vinexin-K, two mammalian members of the recently
described adapter protein family vinexin [26], must have the
ability to bind £o-1 throughout their sorbin homology do-
main in their N-terminal regions. These proteins also contain
three Src homology 3 domains in their C-terminal region,
which allow binding to speci¢c signaling and cytoskeletal mol-
ecules. In addition, it has been described that these adapter
proteins have a role in cell adhesion and cytoskeletal organi-
zation through their binding to vinculin, an actin binding cy-
toskeletal protein localized in the cell^extracellular matrix and
at cell^cell adhesion sites [26]. Further experiments must be
performed to verify this interaction pathway, which would
support the relationship between lipid rafts at the plasma
membrane and the setting up of cellular adhesion structures
via £o-1.
Flo-1 has largely been described as a plasma membrane-
associated protein and, consequently, it should mainly be
found in the hydrophobic cell fraction. However, in our pro-
tein analysis, we observed that the £o-1 content of the hydro-
philic fraction was also signi¢cantly increased during culture
growth from 24 h to 96 h (Fig. 5B). This high accumulation of
£o-1 outside the membrane has not been reported before. The
hydrophilic fraction of cells that reached total con£uence, at
72 h or 96 h, contained higher £o-1 levels than cells at 24 h or
48 h when cell^cell interactions were not fully established.
Moreover, £o-1 levels at 96 h in the hydrophilic fraction
were equivalent or higher than in the hydrophobic fraction
(Fig. 5B). These results indicate that £o-1 is both a strongly
membrane-associated protein (hydrophobic protein fraction)
and a peripheral or putatively cytoplasmic protein (hydro-
philic protein fraction) in NIH-3T3 cells. Morrow and col-
leagues [27] support the hypothesis that £o-1 associates with
the cytoplasmic face of the plasma membrane via a novel
plasma membrane targeting mechanism involving the prohib-
itin-like domain (PHB) and palmitoylation sites in the N-ter-
minal region of the £o-1 protein. The hydrophobic PHB do-
main acts like a lipid raft recognition motif, which targets the
£o-1 protein to the plasma membrane via a Golgi-independent
tra⁄cking pathway. In addition, the association of £o-1 with
the plasma membrane is dependent on protein palmitoylation.
Further, the signi¢cance of protein palmitoylation in lipid raft
targeting has been recognized owing to the existence of regu-
lated depalmitoylation in response to certain stimuli that
might imply protein translocation from the membrane to
the cytoplasm [28]. Our results showing enrichment of £o-1
in the hydrophilic fraction in a manner related to cell^cell
interactions might be explained in two ways: (a) profuse
amounts of £o-1 in the hydrophilic fraction could be due to
the saturation of protein at the membrane rafts when cell
contacts are fully established; (b) regulated translocation
from the membrane to the cytoplasm could take place in
response to stimuli derived from the establishment of cell^
cell interactions. Based on these results, the functional signi¢-
cance of £o-1 protein outside the membrane should be ex-
plored in further studies. Our results with caveolin con¢rm
a previous report about the increase of this protein also asso-
ciated with cell^cell interactions [29].
To analyze expression of the regulatory regions acting at cis
in the £o-1 gene, we isolated and characterized the genomic
region corresponding to its promoter, and analyzed the
5P £anking sequence of the £o-1 transcription start site. This
promoter region contained a 279 bp putative CpG island
highly conserved in sequence and location, although it was
somewhat shorter than that described for the human £o-1
CpG island [24]. No TATA box consensus sequence was
found in this promoter region, as in the human gene. In con-
trast, a CAAT box was found at an expected site, related to
the transcription start site (Figs. 2 and 3). We also found two
consensus Sp1 binding sites near the transcription start site,
one located within the CpG island. Intriguingly, we found
several binding sites for transcription factors that are mostly
involved in the regulation of hematopoietic cell di¡erentia-
tion: AML-1a [30] and MZF1 [31] in myeloid cell di¡erentia-
tion, and c-Ets-1 [32] and Lyf-1 [33] in lymphoid cell di¡er-
entiation. The presence of binding sites for these transcription
factors is in agreement with the presence of £o-1 in mono-
cytes, in the lipid rafts of the macrophage-like cell line J774
[11,34], in those of Jurkat T cells [8], and in erythrocyte plas-
ma membranes [35]. In erythrocytes, £o-1 was detected as one
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of the major proteins associated with lipid rafts, together with
stomatin and £otillin-2. No evidence was found for elements
binding speci¢c transcription factors that might explain the
pattern of £o-1 expression after the disruption of NIH-3T3
cell^cell interactions. Nevertheless, in the luciferase functional
assays, the presence of a second element for MZF1 binding in
the fP-1 construct, with respect to fP-2, was su⁄cient to in-
crease luciferase activity to more than twice that of the other
domains analyzed in the NIH-3T3 cells transfected (Fig. 3).
Therefore, this short 5P promoter fragment might play an
important role in enhancing £o-1 expression.
Evidence for alternative splicing of the £o-1 transcript was
detected in speci¢c tissues after databank analysis. This has
not been described in humans [24]. We found several EST
sequences (see Section 3 for accession numbers) in databases
corresponding to the £o-1 gene with exon 4 deleted (in mam-
mary tumor, olfactory epithelium, and neonate cortex mouse
expression libraries). The mRNA lacking the exon 4 would
theoretically encode a truncated £o-1 at the C-terminal end.
However, an alternative open reading frame would encode the
whole £o-1 except for the ¢rst 79 amino acids of the N-ter-
minal end. This N-terminal region would correspond to part
of the described PHB domain [27]. The signi¢cance of this
putative alternative splicing should be analyzed in further ex-
periments.
In conclusion, (i) in NIH-3T3 cells with established cell^cell
interactions the expression of £otillin-1 is modulated depend-
ing on the level of these interactions. This confers upon £o-
tillin-1 a potential role in cell processes where cellular inter-
actions may be required for normal or pathological
conditions; (ii) the conspicuous presence of £otillin-1 outside
its classically de¢ned location in the membrane may provide
new ways to study its role in the cell ; (iii) the promoter region
of £otillin-1, with its speci¢c regulatory domains, has been
de¢ned. This may help in further studies on the regulation
and function of this protein.
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